Emory University was awarded a $586,875 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2026 to elucidate and exploit SAMHD1 for breast cancer therapy. Through this funding, Emory University researchers will investigate medical solutions for breast cancer by exploring the role of the SAMHD1 protein and developing new therapeutic approaches for patients. The grant supports the program's goals of transforming health care for Service Members and the public through innovative biomedical research.
Generated 1/6/24, 6:15 PM